Another Vaccine just announced,” Trump tweeted Monday morning after Moderna announced that its candidate appeared in early testing to be 95% effective against the virus. “For those great ‘historians’, please remember that these great discoveries, which will end the China Plague, all took place on my watch!”
On a call Monday with governors, Vice President Mike Pence, who heads the White House coronavirus task force, struck a rosy tone and asked states to give their residents comfort that vaccines are coming and that “America and your state has never been more prepared.”
Another Vaccine just announced,” Trump tweeted Monday morning after Moderna announced that its candidate appeared in early testing to be 95% effective against the virus. “For those great ‘historians’, please remember that these great discoveries, which will end the China Plague, all took place on my watch!”
On a call Monday with governors, Vice President Mike Pence, who heads the White House coronavirus task force, struck a rosy tone and asked states to give their residents comfort that vaccines are coming and that “America and your state has never been more prepared.”
That didn’t stop Louisiana Gov. John Bel Edwards from appealing to Pence and Trump for a more unified message on the importance of social distancing and wearing masks. And Dr. Deborah Birx, the task force coordinator, reported that 27 states were in the “red zone” for widespread transmission of the virus — more widespread and worrisome than spikes seen earlier this year.
Biden, who has warned of a “dark winter” ahead on the virus, called for the Trump administration to share its vaccine distribution plans with his own incoming administration, warning that “more people may die if you don’t coordinate.”
Saying vaccine plans are vital to repairing the nation’s economy, Biden said, “If we have to wait until Jan. 20 to start that planning, it puts us behind.”
Biden said he was hopeful that Trump “will be mildly more enlightened before we get to Jan. 20.” He said he understood Trump’s “reluctance” to admit defeat and share his administration’s plans but called it “a shame.”
There’s no progress in Congress yet, either. The split-decision election — in which Democrats absorbed sizable losses in House races despite defeating Trump — hasn’t sparked any progress or prodded House Speaker Nancy Pelosi, D-Calif., or Senate Majority Leader Mitch McConnell, R-Ky., to move from their pre-election postures.
Pelosi wants to go big, say $2 trillion; McConnell wants a smaller package in the $500 billion range that his rightward-tilting colleagues can live with. Moving toward somewhere in the middle would be difficult for both camps.
That didn’t stop Louisiana Gov. John Bel Edwards from appealing to Pence and Trump for a more unified message on the importance of social distancing and wearing masks. And Dr. Deborah Birx, the task force coordinator, reported that 27 states were in the “red zone” for widespread transmission of the virus — more widespread and worrisome than spikes seen earlier this year.
Biden, who has warned of a “dark winter” ahead on the virus, called for the Trump administration to share its vaccine distribution plans with his own incoming administration, warning that “more people may die if you don’t coordinate.”
Saying vaccine plans are vital to repairing the nation’s economy, Biden said, “If we have to wait until Jan. 20 to start that planning, it puts us behind.”
Biden said he was hopeful that Trump “will be mildly more enlightened before we get to Jan. 20.” He said he understood Trump’s “reluctance” to admit defeat and share his administration’s plans but called it “a shame.”
There’s no progress in Congress yet, either. The split-decision election — in which Democrats absorbed sizable losses in House races despite defeating Trump — hasn’t sparked any progress or prodded House Speaker Nancy Pelosi, D-Calif., or Senate Majority Leader Mitch McConnell, R-Ky., to move from their pre-election postures.
Pelosi wants to go big, say $2 trillion; McConnell wants a smaller package in the $500 billion range that his rightward-tilting colleagues can live with. Moving toward somewhere in the middle would be difficult for both camps.
he explained. “(Each) state will decide and tell us where to deliver those vaccines — for instance, into elderly nursing homes or into pharmacies.”
Millions of doses of the Pfizer and Moderna vaccines are already stockpiled, and Slaoui said he expects two additional vaccines in the pipeline will also be approved.
“Some may be best suited for frail, elderly people. Some may be best suited for babies. Some may be best suited for health care workers,” he said. “It’s by adding all these vaccines over time that we feel confident.”
The question now is whether Americans feel confident in getting the vaccines.
“We now have to convince people” that the science is solid, said Dr. Anthony Fauci, the nation’s top expert on infectious diseases.
“We’ve already crossed the line of efficacy. We’re there,” Fauci continued. “We’ve got to get people to be vaccinated.”
Slaoui agreed and said transparency will be key in getting people on board.
“We will make every data available,” Slaoui said. “We will explain to everyone how we went fast
he explained. “(Each) state will decide and tell us where to deliver those vaccines — for instance, into elderly nursing homes or into pharmacies.”
Millions of doses of the Pfizer and Moderna vaccines are already stockpiled, and Slaoui said he expects two additional vaccines in the pipeline will also be approved.
“Some may be best suited for frail, elderly people. Some may be best suited for babies. Some may be best suited for health care workers,” he said. “It’s by adding all these vaccines over time that we feel confident.”
The question now is whether Americans feel confident in getting the vaccines.
“We now have to convince people” that the science is solid, said Dr. Anthony Fauci, the nation’s top expert on infectious diseases.
“We’ve already crossed the line of efficacy. We’re there,” Fauci continued. “We’ve got to get people to be vaccinated.”
Slaoui agreed and said transparency will be key in getting people on board.
“We will make every data available,” Slaoui said. “We will explain to everyone how we went fast
he explained. “(Each) state will decide and tell us where to deliver those vaccines — for instance, into elderly nursing homes or into pharmacies.”
Millions of doses of the Pfizer and Moderna vaccines are already stockpiled, and Slaoui said he expects two additional vaccines in the pipeline will also be approved.
“Some may be best suited for frail, elderly people. Some may be best suited for babies. Some may be best suited for health care workers,” he said. “It’s by adding all these vaccines over time that we feel confident.”
The question now is whether Americans feel confident in getting the vaccines.
“We now have to convince people” that the science is solid, said Dr. Anthony Fauci, the nation’s top expert on infectious diseases.
“We’ve already crossed the line of efficacy. We’re there,” Fauci continued. “We’ve got to get people to be vaccinated.”
Slaoui agreed and said transparency will be key in getting people on board.
“We will make every data available,” Slaoui said. “We will explain to everyone how we went fast
he explained. “(Each) state will decide and tell us where to deliver those vaccines — for instance, into elderly nursing homes or into pharmacies.”
Millions of doses of the Pfizer and Moderna vaccines are already stockpiled, and Slaoui said he expects two additional vaccines in the pipeline will also be approved.
“Some may be best suited for frail, elderly people. Some may be best suited for babies. Some may be best suited for health care workers,” he said. “It’s by adding all these vaccines over time that we feel confident.”
The question now is whether Americans feel confident in getting the vaccines.
“We now have to convince people” that the science is solid, said Dr. Anthony Fauci, the nation’s top expert on infectious diseases.
“We’ve already crossed the line of efficacy. We’re there,” Fauci continued. “We’ve got to get people to be vaccinated.”
Slaoui agreed and said transparency will be key in getting people on board.
“We will make every data available,” Slaoui said. “We will explain to everyone how we went fast
Source https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine.
As part of the arrangement under OWS, representatives from NIAID, BARDA and Moderna are part of the oversight group that receives recommendations from the trial’s independent DSMB. The same DSMB also oversees the additional OWS-supported Phase 3 clinical trials evaluating COVID-19 vaccine candidates.
The co-principal investigators for the study are Hana M. El Sahly, M.D., principal investigator of the NIAID-funded Infectious Diseases Clinical Research Consortium site at Baylor College of Medicine in Houston; Lindsey R. Baden, M.D., principal investigator of the NIAID-funded Harvard HIV Vaccine Clinical Trials Unit at Brigham and Women’s Hospital in Boston; and Brandon Essink, M.D., principal investigator and medical director of Meridian Clinical Research.
More detailed information about the trial, including more comprehensive data, will be available in a forthcoming report. For more information about the trial, visit clinicaltrials.gov and search identifier NCT04470427.
Source https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine.
As part of the arrangement under OWS, representatives from NIAID, BARDA and Moderna are part of the oversight group that receives recommendations from the trial’s independent DSMB. The same DSMB also oversees the additional OWS-supported Phase 3 clinical trials evaluating COVID-19 vaccine candidates.
The co-principal investigators for the study are Hana M. El Sahly, M.D., principal investigator of the NIAID-funded Infectious Diseases Clinical Research Consortium site at Baylor College of Medicine in Houston; Lindsey R. Baden, M.D., principal investigator of the NIAID-funded Harvard HIV Vaccine Clinical Trials Unit at Brigham and Women’s Hospital in Boston; and Brandon Essink, M.D., principal investigator and medical director of Meridian Clinical Research.
More detailed information about the trial, including more comprehensive data, will be available in a forthcoming report. For more information about the trial, visit clinicaltrials.gov and search identifier NCT04470427.
This study was compiled by over a hundred facilities across the nation each independently monitoring those infected and whether they received a placebo independently.
A list is availible here it involved 30000 Americans from different ethnicities. .
Scroll to bottom to understand the independent data collecting sites.
This study was compiled by over a hundred facilities across the nation each independently monitoring those infected and whether they received a placebo independently.
A list is availible here it involved 30000 Americans from different ethnicities. .
Scroll to bottom to understand the independent data collecting sites.
WHO chief medical.officer states, "The interim results are very encouraging but more information is needed. " CNN headline bar.
Pfizer and Moderna must file for emergency authorization clearance. This will give us time for more data to be released. CDC.
We have two vaccines ready however we are not capable of distribution of vaccines.
Logistically it will be a slow process for Maine and other states to distribute these vaccines without more resources.
"We going to need technitions qualified to administer vaccine. Cold chain process for Pfizer makes it feasible in urban centers
Moderna is ideal dealing with ruralcenters such as down east ( Machias hospital for example) "Dr Shah director of cdc maine.
Moderna states they are on schedual to delivering 1 billion doses to world wide distribution by end of 2021.
Lorena has activated medical product manufacturing across the globe.
Swiss government has confirmed reserving vaccines for population.
Two most promising vaccines left to state clinical trial 3 studies. Johnson and Johnson. Astra zeneca.
Johnson and Johnson is turning to medical supply division for needed equipment to deliver the vaccine.
States are working to coordinate phase rollouts of clinical doses.
Government and Labor workers deemed essential workers not allowed to be laid off or receive unemployment insurance benefits be allowed essential workers priority...
Biden urges Trump to cooperate with transition teams on distribution plans of pending approved vaccines
We should have emergency distribution 60 million doses schedual met by Dec 21st....
God speed and God bless the United states.
.
WHO chief medical.officer states, "The interim results are very encouraging but more information is needed. " CNN headline bar.
Pfizer and Moderna must file for emergency authorization clearance. This will give us time for more data to be released. CDC.
We have two vaccines ready however we are not capable of distribution of vaccines.
Logistically it will be a slow process for Maine and other states to distribute these vaccines without more resources.
"We going to need technitions qualified to administer vaccine. Cold chain process for Pfizer makes it feasible in urban centers
Moderna is ideal dealing with ruralcenters such as down east ( Machias hospital for example) "Dr Shah director of cdc maine.
Moderna states they are on schedual to delivering 1 billion doses to world wide distribution by end of 2021.
Lorena has activated medical product manufacturing across the globe.
Swiss government has confirmed reserving vaccines for population.
Two most promising vaccines left to state clinical trial 3 studies. Johnson and Johnson. Astra zeneca.
Johnson and Johnson is turning to medical supply division for needed equipment to deliver the vaccine.
States are working to coordinate phase rollouts of clinical doses.
Government and Labor workers deemed essential workers not allowed to be laid off or receive unemployment insurance benefits be allowed essential workers priority...
Biden urges Trump to cooperate with transition teams on distribution plans of pending approved vaccines
We should have emergency distribution 60 million doses schedual met by Dec 21st....
God speed and God bless the United states.
.
Leaders of Operation Warp Speed, the Trump administration's program to fast-track vaccines and therapeutics, are hopeful. Gen. Gus Perna, the Army logistics commander overseeing vaccine logistics, confirmed that the government will begin shipping vaccines to ZIP codes across the country within 24 hours of FDA approval.
By the end of December, roughly 20 million people could be vaccinated against the coronavirus, Moncef Slaoui, co-lead of Operation Warp Speed, said Friday. Another 25 to 30 million people will likely get the vaccine in each of the following months until more vaccine candidates are approved. That could mean up to a quarter of the U.S. population inoculated by the spring.
Leaders of Operation Warp Speed, the Trump administration's program to fast-track vaccines and therapeutics, are hopeful. Gen. Gus Perna, the Army logistics commander overseeing vaccine logistics, confirmed that the government will begin shipping vaccines to ZIP codes across the country within 24 hours of FDA approval.
By the end of December, roughly 20 million people could be vaccinated against the coronavirus, Moncef Slaoui, co-lead of Operation Warp Speed, said Friday. Another 25 to 30 million people will likely get the vaccine in each of the following months until more vaccine candidates are approved. That could mean up to a quarter of the U.S. population inoculated by the spring.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.